Beijing Kawin Technology Share-Holding Co., Ltd.

Focusing on viral and immune diseases, Kawin can offer matured products based upon our specialty in interferon strain management, in EP standard. We also can provide product licensing opportunities like our portfolio of Glycyrrhizin products that have been popularized in dermatology and hepatology. Transfer of Interferon & GCSF (both conventional & pegylated), and kinds of mAbs (Nivolumab) are also open to discussion.